Relmada Therapeutics Plunges 25.22% Amid Volatile Trading

On April 24, 2025, Relmada Therapeutics experienced a significant drop of 25.22% in pre-market trading, marking a notable decline in its stock performance.

Relmada Therapeutics has seen a volatile trading session, with its stock price experiencing significant fluctuations. The company's shares declined by 20.4% during Wednesday's after-market session, reflecting investor concerns and market sentiment. This decline follows a previous drop of 82.54% earlier in the day, indicating a challenging period for the biopharmaceutical company.

Despite the recent downturn, Relmada Therapeutics had previously shown positive momentum with a 29.84% surge in its stock price during Wednesday's session, reaching $0.49. This surge was driven by a 25.17% increase in share price over the past month, suggesting that the company had been experiencing some positive developments.

However, the recent declines highlight the volatility and uncertainty surrounding Relmada Therapeutics' stock. Investors are likely monitoring the company's performance closely, awaiting further updates on its clinical trials and regulatory developments, which could impact its stock price in the coming days.